Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GrafixPL PRIME Evaluation Case Study
NCT03742440Phase 4Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Nov 2018
- Primary completion
- Mar 2020
- Modality
- Implantable Devices, Implantable Hydrogels, Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of GrafixPL PRIME in diabetic foot ulcer (DFU), sponsored by UT Southwestern Medical Center. Primary endpoint: Number of Participants With Complete Closure of the Index Ulcer at 12 weeks. Started Nov 2018; status: completed.
02
Drugs
GrafixPL PRIME
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT03742440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03742440.